nabumetone

Generic: nabumetone

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nabumetone
Generic Name nabumetone
Labeler actavis pharma, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

nabumetone 500 mg/1

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0591-3670
Product ID 0591-3670_50a45f4a-452a-43d5-8f93-38b1023dec1e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091083
Listing Expiration 2026-12-31
Marketing Start 2011-06-13

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05913670
Hyphenated Format 0591-3670

Supplemental Identifiers

RxCUI
311892 311893
UPC
0305913670013
UNII
LW0TIW155Z
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nabumetone (source: ndc)
Generic Name nabumetone (source: ndc)
Application Number ANDA091083 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-01)
  • 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-05)
source: ndc

Packages (2)

Ingredients (1)

nabumetone (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "50a45f4a-452a-43d5-8f93-38b1023dec1e", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0305913670013"], "unii": ["LW0TIW155Z"], "rxcui": ["311892", "311893"], "spl_set_id": ["53656d70-6572-4669-6465-6c6973555341"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-01)", "package_ndc": "0591-3670-01", "marketing_start_date": "20110613"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-05)", "package_ndc": "0591-3670-05", "marketing_start_date": "20110613"}], "brand_name": "Nabumetone", "product_id": "0591-3670_50a45f4a-452a-43d5-8f93-38b1023dec1e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "0591-3670", "generic_name": "Nabumetone", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nabumetone", "active_ingredients": [{"name": "NABUMETONE", "strength": "500 mg/1"}], "application_number": "ANDA091083", "marketing_category": "ANDA", "marketing_start_date": "20110613", "listing_expiration_date": "20261231"}